These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8480984)
1. [Simultaneous prescription of digoxin and an anti-arrhythmia agent, is it dangerous?]. Chauvin M; Brechenmacher C Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):39-44. PubMed ID: 8480984 [TBL] [Abstract][Full Text] [Related]
2. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. Nestico PF; Morganroth J Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932 [TBL] [Abstract][Full Text] [Related]
3. The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study. Leahey EB; Reiffel JA; Giardina EG; Bigger JT Ann Intern Med; 1980 May; 92(5):605-8. PubMed ID: 7387000 [TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of the newer antiarrhythmic agents. Gillis AM; Kates RE Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. Luedtke SA; Kuhn RJ; McCaffrey FM Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449 [TBL] [Abstract][Full Text] [Related]
6. [Drug therapy in supraventricular arrhythmia]. Follath F; Candinas R; Meyer B Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic agents: drug interactions of clinical significance. Trujillo TC; Nolan PE Drug Saf; 2000 Dec; 23(6):509-32. PubMed ID: 11144659 [TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Verschraagen M; Koks CH; Schellens JH; Beijnen JH Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640 [TBL] [Abstract][Full Text] [Related]
9. [Combinations of some anti-arrhythmia drugs]. Di Marcotullio G; Milazzotto F; Dini P; Santini M; Ceci V; Polizzi C G Ital Cardiol; 1984 May; 14(5):360-6. PubMed ID: 6147292 [TBL] [Abstract][Full Text] [Related]
13. Mixed-effect modeling for detection and evaluation of drug interactions: digoxin-quinidine and digoxin-verapamil combinations. Bauer LA; Horn JR; Pettit H Ther Drug Monit; 1996 Feb; 18(1):46-52. PubMed ID: 8848820 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of interactions of anti-arrhythmia agents during their combined use]. Adnan Abdalla ; Mazur NA; Shestakova NV Kardiologiia; 1991 Feb; 31(2):87-91. PubMed ID: 2041300 [No Abstract] [Full Text] [Related]
15. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of old and new antiarrhythmic drugs. Siddoway LA; Roden DM; Woosley RL Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805 [TBL] [Abstract][Full Text] [Related]
18. [Unwanted drug interaction between anti-arrhythmic drugs and drugs used for heart failure]. Jaźwińska-Tarnawska E; Orzechowska-Juzwenko K Pol Merkur Lekarski; 2000 Sep; 9(51):614-7. PubMed ID: 11126988 [TBL] [Abstract][Full Text] [Related]